The persistence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after SARS-CoV-2 infection: A systematic review and meta-analysis.

Autor: Dehlia A; School of Life and Environmental Sciences, Deakin University, Burwood, VIC, Australia., Guthridge MA; School of Life and Environmental Sciences, Deakin University, Burwood, VIC, Australia. Electronic address: m.guthridge@deakin.edu.au.

Publikováno v: The Journal of infection [J Infect] 2024 Dec; Vol. 89 (6), pp. 106297. Date of Electronic Publication: 2024 Sep 29.

Differences in Genomic Alterations and Accumulations of Heavy Metals Between Advanced Non-small Cell Lung Cancer Patients with and without Bone Metastasis.

Autor: Zhong-Qiang Yao¹, Hui-Hui Jiang² jianghh@biotecan.com, Fei-Fei Wang¹, Zhi-Gang Fan¹, Yi-Ge Zhang¹, Shang-Dong Mou¹, Xia Cao¹, Cheng-Tian Li¹, Li-Sha Jiang¹, Li Song², Shu-Shen Ji², Qing-Juan Chen¹ chenqingjuan2023@163.com

Publikováno v: Journal of Cancer. 2024, Vol. 15 Issue 13, p4205-4218. 14p.

Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1.

Autor: Teh TC; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Victoria, Australia., Nguyen NY; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia., Moujalled DM; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia., Segal D; Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.; Departments of Medicine and Medical Biology, Faculty of Medicine, University of Melbourne, Parkville, Victoria. Australia., Pomilio G; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia., Rijal S; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia., Jabbour A; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia., Cummins K; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Victoria, Australia., Lackovic K; Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.; Departments of Medicine and Medical Biology, Faculty of Medicine, University of Melbourne, Parkville, Victoria. Australia., Blombery P; Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Thompson E; Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Ekert PG; Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia., Lessene G; Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.; Departments of Medicine and Medical Biology, Faculty of Medicine, University of Melbourne, Parkville, Victoria. Australia., Glaser SP; Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.; Departments of Medicine and Medical Biology, Faculty of Medicine, University of Melbourne, Parkville, Victoria. Australia., Huang DCS; Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.; Departments of Medicine and Medical Biology, Faculty of Medicine, University of Melbourne, Parkville, Victoria. Australia., Roberts AW; Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.; Departments of Medicine and Medical Biology, Faculty of Medicine, University of Melbourne, Parkville, Victoria. Australia.; Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.; Department of Clinical Hematology and BMT, The Royal Melbourne Hospital, Royal Parade, Parkville, Victoria, Australia., Guthridge MA; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia., Wei AH; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Victoria, Australia.

Publikováno v: Leukemia [Leukemia] 2018 Feb; Vol. 32 (2), pp. 303-312. Date of Electronic Publication: 2017 Jul 28.

Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.

Autor: Hein N; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Cameron DP; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Hannan KM; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, VIC, Australia., Nguyen NN; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Fong CY; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sornkom J; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Wall M; Victorian Cancer Cytogenetics Service, St. Vincent's Hospital, Fitzroy, VIC, Australia.; Department of Medicine, St. Vincent's Hospital, and., Pavy M; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia., Cullinane C; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Diesch J; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Devlin JR; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., George AJ; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Department of Pathology, The University of Melbourne, Parkville, VIC, Australia.; School of Medical Sciences, University of Queensland, St. Lucia, QLD, Australia., Sanij E; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Pathology, The University of Melbourne, Parkville, VIC, Australia., Quin J; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Poortinga G; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Pathology, The University of Melbourne, Parkville, VIC, Australia., Verbrugge I; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Baker A; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Drygin D; Pimera Inc, San Diego, CA., Harrison SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Rozario JD; Clinical Haematology Unit, The Canberra Hospital, Canberra, ACT, Australia., Powell JA; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.; Schools of Medicine and Biological Sciences, University of Adelaide, SA, Australia., Pitson SM; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.; Schools of Medicine and Biological Sciences, University of Adelaide, SA, Australia., Zuber J; Research Institute of Molecular Pathology, Vienna, Austria., Johnstone RW; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Pathology, The University of Melbourne, Parkville, VIC, Australia., Dawson MA; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Guthridge MA; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Wei A; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.; Department of Clinical Haematology, The Alfred Hospital, Melbourne, VIC, Australia; and., McArthur GA; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Pearson RB; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, VIC, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia., Hannan RD; Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, VIC, Australia.; School of Medical Sciences, University of Queensland, St. Lucia, QLD, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.

Publikováno v: Blood [Blood] 2017 May 25; Vol. 129 (21), pp. 2882-2895. Date of Electronic Publication: 2017 Mar 10.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.